Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, signaling a new version of the page content. This appears to be an editorial or QC update rather than a substantive change to the study details or outcomes.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s displayed system “Revision” number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated to v3.5.2; the previous v3.5.0 revision was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedFooter Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check107 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 with no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.